European Archives - Page 694 of 1507 - European Medical Journal

EMJ

Corrigendum: Five Considerations when Selecting Adjunctive Treatment for Drug-Resistant Epilepsy

In the infographic published under EMJ Neurology, the table titled ‘Summary of Key Considerations Relating to Adjunctive Treatment Options…

Dietary Approaches Surpass Medications in Management of Irritable Bowel Syndrome

A study from University of Gothenburg, Sweden, states that dietary management surpasses medications for irritable bowel syndrome, with about 70% experiencing significant symptom improvement,

Endoscopy: Could Diabetes Medication Increase Gastric Contents Retention?

GLP1-RA drugs for diabetes may heighten risk of gastric retention during upper endoscopy. Research suggests continued use may not warrant procedure cancellations.

A Personalised Approach to Diabetes

This episode explores self-management in diabetes and inequality in the field with Nick Oliver, Wynn Professor of Human Metabolism at Imperial College Healthcare NHS Trust.

Younger Patients With Atrial Fibrillation Face Heightened Mortality Risk

A new study shed light on the concerning risk factors and outcomes faced by individuals under 65 years old diagnosed with atrial fibrillation.

Retracted: BMS ECCO 2024 Symposium

BMS has requested the removal of these sponsored materials.

Improved Breast Cancer Detection in Females

New research has demonstrated that combining contrast-enhanced mammography and digital breast tomosynthesis increases early breast cancer detection amongst females with a history of the disease.

Digital Interventions for Psoriatic Arthritis Screening in Primary Care

Psoriasis (PsO) is a chronic inflammatory skin condition that affects around 2% of the population in Europe…

Artificial Intelligence in Robotic Urologic Surgery

This infographic explores the emerging role of artificial intelligence in robotic urologic surgery, with a spotlight on the current…

Spotlight: April 2024

Catch up on the top stories to come from the pharma industry over April, including new collaborations set to improve treatments for patients, the latest approvals and more.